Article
Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells.
Lung cancer (Amsterdam, Netherlands) - 1 Jan 2012
Han Shu-Yan, Zhao Ming-Bo, Zhuang Gui-Bao, Li Ping-Ping
Abstract excerpt
Most non-small cell lung cancer (NSCLC) patients responding to gefitinib harbor activating mutations in the epidermal growth factor receptor (EGFR). However, the responsive cases eventually develop the resistance to gefitinib. Besides, K-ras mutations were identified as the primary resistance to gefitinib. We investigated whether Marsdenia tenacissima extract (MTE, trade name: Xiao-Ai-Ping injection) combined...
Topics
- Antineoplastic Agents
- Apoptosis
- Carcinoma, Non-Small-Cell Lung
- Cell Line, Tumor
- Cell Proliferation
- Drug Resistance, Neoplasm
- Drug Synergism
- ErbB Receptors
- Gefitinib
- Genes, ras
- Humans
